195 related articles for article (PubMed ID: 313960)
1. Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR.
Knapp MR; Jones PP; Black SJ; Vitetta ES; Slavin S; Strober S
J Immunol; 1979 Sep; 123(3):992-9. PubMed ID: 313960
[TBL] [Abstract][Full Text] [Related]
2. Expression, distribution and specificity of Fc receptors for IgM on murine B cells.
Mathur A; Lynch RG; Köhler G
J Immunol; 1988 Sep; 141(6):1855-62. PubMed ID: 2971716
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
Ciavarra RP; Vitetta ES; Forman J
J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
[TBL] [Abstract][Full Text] [Related]
4. Activation of B cells in vivo by a Fab/Fc fragment of a monoclonal anti-IgD antibody requires an interaction between the antibody fragment and a cellular IgG Fc receptor.
Goroff DK; Finkelman FD
J Immunol; 1988 May; 140(9):2919-24. PubMed ID: 2966202
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.
Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S
J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513
[TBL] [Abstract][Full Text] [Related]
6. Membrane IgM influences membrane IgD mediated antigen internalization in the B cell line Bcl1.
Geisberger R; Königsberger S; Achatz G
Immunol Lett; 2006 Feb; 102(2):169-76. PubMed ID: 16219364
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
Goroff DK; Stall A; Mond JJ; Finkelman FD
J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
[TBL] [Abstract][Full Text] [Related]
8. Influence of IgH V-region genes on the growth kinetics of a murine B cell leukemia (BCL1).
Ciavarra R; Forman J
J Immunol; 1981 Jan; 126(1):54-8. PubMed ID: 6778917
[TBL] [Abstract][Full Text] [Related]
9. Receptor mediated leukemogenesis: murine leukemia virus interacts with BCL1 lymphoma cell surface IgM.
McGrath MS; Tamura G; Weissman IL
J Mol Cell Immunol; 1987; 3(4):227-42. PubMed ID: 2855408
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
11. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population.
Finkelman FD; Mond JJ; Metcalf ES
J Immunol; 1983 Aug; 131(2):593-600. PubMed ID: 6602840
[TBL] [Abstract][Full Text] [Related]
12. B-1a cell origin of the murine B lymphoma line BCL1 characterized by surface markers and bacterial reactivity of its surface IgM.
Koganei S; Ito M; Yamamoto K; Matsumoto N
Immunol Lett; 2005 May; 98(2):232-44. PubMed ID: 15860223
[TBL] [Abstract][Full Text] [Related]
13. The relationship between surface immunoglobulin isotype and immune function of murine B lymphocytes. IV. Role of IgD-bearing cells in the propagation of immunologic memory.
Zan-Bar I; Strober S; Vitetta ES
J Immunol; 1979 Aug; 123(2):925-30. PubMed ID: 313424
[No Abstract] [Full Text] [Related]
14. Characterization of a spontaneous murine B cell leukemia (BCL1). II. Tumor cell proliferation and IgM secretion after stimulation by LPS.
Knapp MR; Severinson-Gronowicz E; Schröder J; Strober S
J Immunol; 1979 Sep; 123(3):1000-6. PubMed ID: 381513
[TBL] [Abstract][Full Text] [Related]
15. Production of BSF-1 during an in vivo, T-dependent immune response.
Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin.
Mond JJ; Seghal E; Kung J; Finkelman FD
J Immunol; 1981 Sep; 127(3):881-8. PubMed ID: 6790620
[TBL] [Abstract][Full Text] [Related]
17. A murine B-cell lymphoma induced by Gross virus.
Numata M; Mitsuboshi Y; Nitta K
Cancer Res; 1981 Apr; 41(4):1492-6. PubMed ID: 6971147
[TBL] [Abstract][Full Text] [Related]
18. Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
Noro N; Adachi M; Yasuda K; Masuda T; Yodoi J
J Immunol; 1986 Apr; 136(8):2910-6. PubMed ID: 3514749
[TBL] [Abstract][Full Text] [Related]
19. Antigen-induced murine B cell lymphomas. I. Induction and characterization of CH1 and CH2.
Lynes MA; Lanier LL; Babcock GF; Wettstein PJ; Haughton G
J Immunol; 1978 Dec; 121(6):2352-7. PubMed ID: 363945
[TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent cellular cytotoxicity effector cells lack Ia antigens.
Nelson DL; Sachs DH; Dickler HB
J Immunol; 1977 Sep; 119(3):1034-40. PubMed ID: 330744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
